首页> 外文期刊>Journal of Breast Cancer >Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea
【24h】

Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea

机译:韩国一所研究所的乳房囊内乳头状癌的经验

获取原文
           

摘要

Intracystic papillary carcinoma (IPC) of the breast is a rare entity, which can be associated with ductal carcinoma in situ (DCIS) or an invasive carcinoma. There have been only limited reports describing IPC in Korea and the incidence among breast cancer cases in Korea has not yet been reported. From a database of 7,109 breast cancer cases treated surgically at Samsung Medical Center, we could only identify four IPC cases (0.056%). We also found that there are some differences between the clinicopathological characteristics of our cases and the alleged characteristics of IPC as reported from Western countries, such as a relatively young age of onset, small tumor size and various expression levels of hormonal receptors. We suspect this very low incidence may be caused by a true rarity of IPC in women in Korea or may be due to a lack of clinical interest for IPC. Upon presentation of our experience with IPC, we suggest the diagnosis for this rare disease entity needs to be reappraised.
机译:乳房的囊内乳头状癌(IPC)是一种罕见的实体,可能与导管原位癌(DCIS)或浸润性癌相关。在韩国描述IPC的报道很少,而在韩国乳腺癌病例中的发病率尚未报道。从三星医疗中心手术治疗的7109例乳腺癌病例的数据库中,我们只能识别出4例IPC病例(0.056%)。我们还发现,根据西方国家的报道,我们病例的临床病理特征与IPC的所谓特征之间存在一些差异,例如发病年龄相对较小,肿瘤较小和激素受体的各种表达水平。我们怀疑这种极低的发病率可能是由于IPC在韩国女性中的真正稀有性​​引起的,或者可能是由于对IPC缺乏临床兴趣所致。在介绍我们在IPC方面的经验后,我们建议需要重新评估这种罕见疾病的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号